Amgen Inc. (AMGN)
NASDAQ · Healthcare
Amgen Inc. Operating Income 2007–2025
Amgen Inc. annual/quarterly operating income history and growth rate from 2007 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Amgen Inc. operating income for the quarter ending March 31, 2026 was 2.7 B, a 126.32% increase year-over-year.
- Amgen Inc. operating income for the twelve months ending March 31, 2026 was 9.0 B, a 29.54% increase year-over-year.
- Amgen Inc. annual operating income for 2025 was 9.1 B, a 25.10% increase from 2024.
- Amgen Inc. annual operating income for 2024 was 7.3 B, a 8.09% decrease from 2023.
- Amgen Inc. annual operating income for 2023 was 7.9 B, a 17.45% decrease from 2022.
- Amgen Inc. annual operating income for 2022 was 9.6 B.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Amgen Inc. Operating Income — FAQ
Amgen Inc. (AMGN) operating income over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
What is Amgen Inc.'s operating income?
Amgen Inc. (AMGN) reported operating income of $9.08B for fiscal 2025.
Where can I see AMGN's operating income history?
The chart and table above show Amgen Inc.'s operating income by year and by quarter, including the growth rate.